Live Breaking News & Updates on நிகில் லல்வானி

Stay updated with breaking news from நிகில் லல்வானி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ANI Pharmaceuticals Inc (ANIP) Q1 2021 Earnings Call Transcript


Operator
Good day everyone, and welcome to today s ANI Pharmaceuticals First Quarter 2021 Earnings Release Call. [Operator Instructions]
It s now my pleasure to turn the conference over to Lisa Wilson. Please go ahead.
Lisa M. Wilson
Investor Relations
Thank you, operator. Welcome to ANI Pharmaceuticals Q1 2021 earnings results call. This is Lisa Wilson of In-Site Communications, Investor Relations for ANI. With me on today s call are Nikhil Lalwani, President and Chief Executive Officer; and Stephen Carey, Chief Financial Officer of ANI. You can also access the webcast of this call through the Investors section of the ANI website at anipharmaceuticals.com. ....

United States , Nikhil Lalwani , Lisam Wilson , Lisa Wilson , Stephen Carey , Sherry Korczynski , Chris Mutz , Stephenp Carey , Site Communications , Pharmaceuticals First Quarter , Ani Pharmaceuticals Inc , First Quarter , In Site Communications , Investor Relations , Chief Executive Officer , Chief Financial Officer , Private Securities Litigation Reform , Chief Executive , Cortrophin Gel , New Drug Application , Chief Commercial Officer , Rare Diseases , Bill Mroczka , Market Access , Competitive Generic Therapy , North American ,

ANI Pharmaceuticals buys Novitum Pharma for $163.5 million


Copy shortlink:
ANI Pharmaceuticals, the Baudette-based maker of generic and specialty drugs, announced plans to acquire Novitium Pharma in a $163.5 million deal that should increase its drug-commercialization capabilities.
Strengthening our well-established generics business with enhanced development capabilities and increased focus on niche opportunities is a key pillar of ANI s growth strategy, Nikhil Lalwani, ANI s chief executive, said in a statement.
Novitium, based in East Windsor, N.J., makes niche generic products in liquid, capsule, tablet and powder forms. It has a 50,000-square-foot facility for manufacturing and research and is adding 20,000 square feet to it.
Lalwani said the state-of-the-art manufacturing facility is a key attraction in the deal. He also said ANI would be able to add more size to its contract development and manufacturing business. ....

Nikhil Lalwani , Samy Shanmugam , Novitium Pharma , Patrick Kennedy , Drug Administration , Ani Pharmaceuticals , East Windsor , Chad Gassert , நிகில் லல்வானி , சமி ஷண்முகம் , பேட்ரிக் கெந்நெடீ , அணி மருந்துகள் , கிழக்கு விண்ட்சர் ,

ANI Pharmaceuticals Inc (ANIP) Q4 2020 Earnings Call Transcript


Operator
Good morning, and welcome to today s program. My name is Maria, and I ll be your conference operator. At this time, I d like to welcome everyone to ANI Pharmaceuticals Fourth Quarter and-Year End 2020 Earnings Results and Business Update Call.
[Operator Instructions] As a reminder, this conference call is being recorded today, March 9th, 2021. It s now my pleasure to turn the floor over to Ms. Lisa Wilson, Investor Relations for ANI Pharmaceuticals. Please go ahead.
Lisa M. Wilson
Investor Relations
Thank you, Maria. Welcome to ANI Pharmaceuticals Q4 2020 Earnings Results Call. This is Lisa Wilson of In-Site Communications, Investor Relations for ANI. ....

United States , New Jersey , Nikhil Lalwani , Lisam Wilson , Dana Flanders Guggenheim , Lisa Wilson , Raymond James , Elliot Wilbur Raymond James , Brandon Folkes Cantor Fitzgerald , Stephenp Carey , Steve Carey , Dana Flanders , Novitium Pharma , Davinder Singh , Elliot Wilbur , Brandon Folkes , Chris Mutz , Site Communications , Cantor Fitzgerald , Rd Center , Pharmaceuticals Fourth Quarter , Ani Pharmaceuticals Inc , Fourth Quarter , Year End , Business Update , Investor Relations ,